ACM
ABMD

American Capital Management’s Abiomed Inc ABMD Stock Holding History

American Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-270,696
Closed -$66.5M – 64
2022
Q3 		$66.5M Sell
270,696
-679
-0.3% -$183K 2.62% 13
2022
Q2 		$67.2M Buy
271,375
+72
+0% +$19.4K 2.52% 16
2022
Q1 		$89.9M Buy
271,303
+8,383
+3% +$2.58M 2.65% 15
2021
Q4 		$94.4M Buy
262,920
+12,272
+5% +$4.15M 2.42% 13
2021
Q3 		$81.6M Buy
250,648
+17,996
+8% +$6.1M 2.19% 16
2021
Q2 		$72.6M Buy
232,652
+11,413
+5% +$3.5M 2.03% 17
2021
Q1 		$70.5M Buy
221,239
+1,566
+0.7% +$501K 2.13% 16
2020
Q4 		$71.2M Buy
219,673
+441
+0.2% +$122K 2.13% 20
2020
Q3 		$60.7M Sell
219,232
-1,855
-0.8% -$534K 2.23% 19
2020
Q2 		$53.4M Buy
221,087
+6,836
+3% +$1.37M 1.96% 20
2020
Q1 		$31.1M Buy
214,251
+65,457
+44% +$10.9M 1.51% 26
2019
Q4 		$25.4M Buy
148,794
+25,124
+20% +$4.66M 1.06% 30
2019
Q3 		$22M Buy
123,670
+43,357
+54% +$9.37M 0.97% 33
2019
Q2 		$20.9M Buy
+80,313
New +$21.3M 0.9% 35

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

American Capital Management's ABMD Position: Q4 2022 in Review

American Capital Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 270,696 shares — an estimated $66.5M sold.

American Capital Management first reported a position in ABMD in Q2 2019 and held it in 14 quarters. The position peaked at $94.4M in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • American Capital Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • American Capital Management sold 270,696 Abiomed Inc shares in Q4 2022, an estimated $66.5M.
  • American Capital Management first reported a position in Abiomed Inc in Q2 2019 and held it in 14 quarters.
  • American Capital Management's Abiomed Inc position peaked at $94.4M in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on American Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.